阿弗利塞普特装载眼滴水凝与细胞透为角膜新血管化治疗的介导

Jianan Zhou1, Yuting Cai2, Tingting Li1

  • 1Hunan Provincial Key Laboratory of Animal Models and Molecular Medicine, State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, School of Biomedical Sciences, Hunan University, Changsha, Hunan, 410082, China.

概括

一种新的眼滴水凝,Gel 2_1&Eylea,通过改善药物输送,有效治疗角膜新血管化 (CoNV). 这种创新的治疗方法在临床前模型中显示出高效率和生物相容性.